氨溴索联合围手术期干预在心胸外科应用价值探讨
|
摘要
目的:研讨氨溴索联合围手术期干预在心胸外科的临床效果与应用价值。方法:抽选2017年5月至2018年5月在本院接受心胸外科手术治疗的86例患者,根据其入院顺序分为对照组与观察组两组,每组43例。其中,对照组采用基础护理,观察组采用氨溴索+围手术期护理。比较两组各项临床情况。结果:治疗护理前,两组患者SAS、SDS评分比较无统计学意义(P>0.05);护理后,观察组SAS、SDS评分低于对照组[(36.40±2.33)分,(35.42±1.30)分vs (43.20±2.21)分,(42.40±2.07)分],且差异有统计学意义(P<0.05)。观察组并发症发生率显著低于对照组(9.30%vs 27.91%),比较差异显著(P<0.05)。观察组护理满意度高于对照组(93.02%vs 72.09%),差异有统计学意义(P<0.05)。结论:在心胸外科手术治疗中应用氨溴索+围手术期护理,可有效改善患者负面情绪,降低并发症几率,使患者得到优质的医疗服务。
Objective: To study the clinical effect and application value of ambroxol combined with perioperative intervention in cardiothoracic surgery. Methods: 86 patients who received cardiothoracic surgery from May 2017 to May 2018 were selected and divided into two groups according to their admission order: control group and observation group with 43 cases in each group. Among them, the control group was treated with basic nursing and the observation group with ambroxol perioperative nursing. The clinical conditions of the two groups were compared. Results: Before treatment and nursing, there was no significant difference in SDS score between the two groups(P>0.05), and after nursing, the SDS score of observation group was lower than that of control group. Group A(36.40 ±2.33, 35.42 ±1.30 vs 43.20 ±2.21, 42.40 ±2.07), and the difference was statistically significant(P<0.05). The incidence of complications in the observation group was significantly lower than that in the control group(9.30 vs 27.91%), and the difference was significant(P<0.05). The nursing satisfaction in the observation group was higher than that in the control group(93.02 vs 72.09%), and the difference was statistically significant(P<0.05). Conclusion: The application of ambroxol in the perioperative nursing of cardiothoracic surgery can effectively improve the negative situation of the patients. Therefore, it reduces complication probability, makes patient get high-quality medical service.
Objective: To study the clinical effect and application value of ambroxol combined with perioperative intervention in cardiothoracic surgery. Methods: 86 patients who received cardiothoracic surgery from May 2017 to May 2018 were selected and divided into two groups according to their admission order: control group and observation group with 43 cases in each group. Among them, the control group was treated with basic nursing and the observation group with ambroxol perioperative nursing. The clinical conditions of the two groups were compared. Results: Before treatment and nursing, there was no significant difference in SDS score between the two groups(P>0.05), and after nursing, the SDS score of observation group was lower than that of control group. Group A(36.40 ±2.33, 35.42 ±1.30 vs 43.20 ±2.21, 42.40 ±2.07), and the difference was statistically significant(P<0.05). The incidence of complications in the observation group was significantly lower than that in the control group(9.30 vs 27.91%), and the difference was significant(P<0.05). The nursing satisfaction in the observation group was higher than that in the control group(93.02 vs 72.09%), and the difference was statistically significant(P<0.05). Conclusion: The application of ambroxol in the perioperative nursing of cardiothoracic surgery can effectively improve the negative situation of the patients. Therefore, it reduces complication probability, makes patient get high-quality medical service.
引文
[1]谭蕾,王学鹏,何子林,等.围手术期应用氨溴索联合心理干预对胸腔镜下肺叶切除术后肺癌患者的疗效分析[J].中国生化药物杂志,2017,37(09):299-300.
[2]张楚,王海勇,崔健.肺癌合并COPD的患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果[J].中华胸心血管外科杂志,2014,30(05):319-320.
[3]卢家彬,宁玉林,彭艳.肺癌合并COPD患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果分析[J].中国现代药物应用,2016,10(16):216-217.
[4]张继芝,李秀娥.心脏瓣膜置换患者围手术期加速康复外科护理[J].护理学杂志,2017,32(16):27-30.
[5]章岳峰,赵琦峰,刘勇,等.心胸外科患者术后获得性肺炎的临床研究[J].中华医院感染学杂志,2015,25(24):5655-5656.
[6]高文婷.快速康复外科理念在心脏外科手术护理中的应用[J].护士进修杂志,2015,10(02):175-177.
[7]梁玉兰,张娜,王文化,等.心脏外科住院患者围手术期精神科会诊分析[J].临床精神医学杂志,2017,27(04):266-268.
[8]张楚,王海勇,崔健.肺癌合并COPD的患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果[J].中华胸心血管外科杂志,2014,30(05):319-320.
[9]张明远.大剂量盐酸氨溴索在胸外科围手术期的肺功能保护[J].中国药物与临床,2017,17(08):1164-1167.
[10]王磊,王彦刚.盐酸氨溴索在胸外科围术期老年患者中的应用[J].中国现代医生,2014,52(19):51-52.
[11]董波.普胸外科手术围手术期肺部并发症的防治[J].医疗装备,2017,30(08):141-142.
[12]王翾.优质护理服务在心胸外科临床护理中的运用[J].临床医药文献电子杂志,2017,4(05):904-904.
[13]降初拉尔布,张曜,卢斌,等.盐酸氨溴索联合异丙托溴铵对肺功能不全手术患者肺功能的影响[J].临床合理用药杂志,2017,10(08):31-32.
[14]方子文,方万强,阮玲玲.不同剂量盐酸氨溴索在非小细胞肺癌围手术期的临床效果[J].中华胸心血管外科杂志,2014,30(02):125-126.
[15]叶书高,刘峰,纪勇.联合应用氨溴索和异丙托溴铵对老年肺癌患者肺叶切除术后肺功能的影响[J].江苏医药,2017,43(24):1764-1766.
[2]张楚,王海勇,崔健.肺癌合并COPD的患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果[J].中华胸心血管外科杂志,2014,30(05):319-320.
[3]卢家彬,宁玉林,彭艳.肺癌合并COPD患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果分析[J].中国现代药物应用,2016,10(16):216-217.
[4]张继芝,李秀娥.心脏瓣膜置换患者围手术期加速康复外科护理[J].护理学杂志,2017,32(16):27-30.
[5]章岳峰,赵琦峰,刘勇,等.心胸外科患者术后获得性肺炎的临床研究[J].中华医院感染学杂志,2015,25(24):5655-5656.
[6]高文婷.快速康复外科理念在心脏外科手术护理中的应用[J].护士进修杂志,2015,10(02):175-177.
[7]梁玉兰,张娜,王文化,等.心脏外科住院患者围手术期精神科会诊分析[J].临床精神医学杂志,2017,27(04):266-268.
[8]张楚,王海勇,崔健.肺癌合并COPD的患者围手术期联合应用盐酸氨溴索和异丙托溴铵的效果[J].中华胸心血管外科杂志,2014,30(05):319-320.
[9]张明远.大剂量盐酸氨溴索在胸外科围手术期的肺功能保护[J].中国药物与临床,2017,17(08):1164-1167.
[10]王磊,王彦刚.盐酸氨溴索在胸外科围术期老年患者中的应用[J].中国现代医生,2014,52(19):51-52.
[11]董波.普胸外科手术围手术期肺部并发症的防治[J].医疗装备,2017,30(08):141-142.
[12]王翾.优质护理服务在心胸外科临床护理中的运用[J].临床医药文献电子杂志,2017,4(05):904-904.
[13]降初拉尔布,张曜,卢斌,等.盐酸氨溴索联合异丙托溴铵对肺功能不全手术患者肺功能的影响[J].临床合理用药杂志,2017,10(08):31-32.
[14]方子文,方万强,阮玲玲.不同剂量盐酸氨溴索在非小细胞肺癌围手术期的临床效果[J].中华胸心血管外科杂志,2014,30(02):125-126.
[15]叶书高,刘峰,纪勇.联合应用氨溴索和异丙托溴铵对老年肺癌患者肺叶切除术后肺功能的影响[J].江苏医药,2017,43(24):1764-1766.